Lumentum Holdings Inc.

(NASDAQ Global Select)
Back to all articles
Bullish +65

Lumentum Trades Below Marvell’s Buyout Offer. Is the Gap a Bargain?

Acquisition Earnings report AI-generated analysis

📉 Lumentum trades at a ~17% discount to Marvell's all-stock buyout offer due to regulatory timelines extending to H1 2028.

💰 Revenue surged 137% YoY to $1.26 billion in Q1 fiscal 2027, with gross margins expanding to 53%.

🤝 Marvell's fixed exchange ratio of 4.5 shares ties Lumentum shareholders' payout directly to Marvell's stock price volatility.

🚀 Company secured second major NPO/CPO win with purchase commitments exceeding $5 billion in the quarter.

📊 Non-GAAP gross margin expanded from 39.4% a year ago to 53.2%, outpacing peer Coherent's growth rate.

🔮 Bernstein maintains an Outperform rating but lowered its price target to $700, below the merger offer value.

⚖️ A $3.2 billion breakup fee is in place if the deal fails on regulatory grounds, providing a cushion for shareholders.

📅 Deal closing is not expected until the first half of 2028 due to necessary regulatory approvals including from China.

Bullish Signals
  • Lumentum reported fiscal Q1 2027 revenue of $1.26 billion, representing a massive 137% year-over-year increase.
  • Gross margins expanded significantly to 53%, demonstrating superior profitability compared to peer Coherent's 40.6%.
  • The company secured its second major NPO/CPO win with purchase commitments exceeding $5 billion, validating its technology leadership.
  • Optical switching demand visibility has expanded significantly, positioning it for a multi-billion-dollar annual revenue stream.
  • Marvell's buyout offer values Lumentum at approximately $760 per share, providing a substantial premium to the current trading price.
Risk Factors
  • The all-stock deal exposes Lumentum shareholders to Marvell Technology's stock volatility, as the payout value fluctuates with MRVL's share price.
Full Analysis
Lumentum (NASDAQ:LITE) is currently trading below Marvell Technology's all-stock buyout offer, creating a merger arbitrage spread of approximately 17%. The deal values Lumentum at roughly $760 per share based on Marvell's current stock price, though the fixed exchange ratio of 4.5 shares means the payout fluctuates directly with Marvell's performance. Regulatory hurdles, particularly in China, and a closing timeline extending to the first half of 2028 contribute to this discount. Lumentum reported exceptional fiscal first-quarter 2027 results with revenue surging 137% year-over-year to $1.26 billion. Gross margins expanded significantly to 53%, outpacing peer Coherent and demonstrating strong operational efficiency in the near- and co-packaged optics sector. The company secured major non-pluggable optical (NPO) and coherent optical switching (OCS) wins, backed by purchase commitments exceeding $5 billion. Analyst sentiment remains cautiously bullish despite a recent price target adjustment from Bernstein, which now sits between Lumentum's current trading price and the implied merger value. Investors face a trade-off: waiting for the deal closes exposes them to Marvell's stock volatility, while exiting early forfeits the premium. Key upcoming catalysts include Marvell's earnings report on December 1, 2026, and potential regulatory rulings that could impact the deal's final valuation.